Eli Lilly : LLY

All Eli Lilly Articles

670 Articles

Lee Jackson | Jun 9, 2016 at 10:40 AM EDT

4 Merrill Lynch US 1 Portfolio Stocks With Big Total Return Potential

With the market pushing through to all-time highs, we are looking for solid total return ideas for investors. Total return…

Chris Lange | Jun 6, 2016 at 1:40 PM EDT

How Credit Suisse Views Major Pharma After ASCO

The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two…

Chris Lange | Jun 2, 2016 at 10:50 AM EDT

Merrill Lynch Picks ASCO Winners

Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology…

Chris Lange | May 29, 2016 at 10:15 AM EDT

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers…

Lee Jackson | May 27, 2016 at 10:50 AM EDT

4 Dividend-Paying Stocks to Help Ride Out the Coming Volatile Summer

Volumes tend to dry up in the summer as traders and investors go on vacation, making it all that much…

Lee Jackson | May 25, 2016 at 10:05 AM EDT

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue…

Chris Lange | May 19, 2016 at 10:20 AM EDT

8 Stocks on the Move After ASCO Cancer Abstracts

ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or…

Lee Jackson | May 11, 2016 at 9:45 AM EDT

3 Safe Blue Chip Stocks to Buy as Markets Could Be in Trouble

With a flight to cash hardly workable for most investors, and Treasury bonds seemingly very rich, quality low-volatility dividend stocks…

Jon C. Ogg | May 10, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com,…

Chris Lange | Apr 25, 2016 at 12:15 PM EDT

What to Expect When Eli Lilly Reports Earnings

Eli Lilly is set to release its first-quarter earnings report before the markets open on Tuesday.

Lee Jackson | Mar 30, 2016 at 11:05 AM EDT

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the…

Chris Lange | Mar 28, 2016 at 9:10 AM EDT

5 Credit Suisse Focus List Stocks With the Most Upside

In a new research report, Credit Suisse highlighted some companies on its U.S. Focus List that stand to have the…

Lee Jackson | Mar 23, 2016 at 10:05 AM EDT

As Institutional Investors Continue to Sell, 4 Safe Dividend Stocks to Buy and Hold

These four solid companies to buy and hold all can do well, and even if the market sells off, the…

Jon C. Ogg | Mar 23, 2016 at 8:45 AM EDT

The Next Mega-Caps: 7 Stocks Likely to Be Worth $100 Billion Soon

24/7 Wall St. has identified seven companies that could easily reach the $100 billion mark to become the next mega-cap…

Paul Ausick | Mar 17, 2016 at 4:04 PM EDT

The 52-Week Low Club for Thursday

March 17, 2016: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Thursday’s…

1 … 29 30 31 32 33 … 45

Eli Lilly : LLY

All Eli Lilly Articles

4 Merrill Lynch US 1 Portfolio Stocks With Big Total Return Potential

How Credit Suisse Views Major Pharma After ASCO

Merrill Lynch Picks ASCO Winners

Key Movers to Look for Ahead of ASCO

4 Dividend-Paying Stocks to Help Ride Out the Coming Volatile Summer

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

8 Stocks on the Move After ASCO Cancer Abstracts

3 Safe Blue Chip Stocks to Buy as Markets Could Be in Trouble

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

What to Expect When Eli Lilly Reports Earnings

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

5 Credit Suisse Focus List Stocks With the Most Upside

As Institutional Investors Continue to Sell, 4 Safe Dividend Stocks to Buy and Hold

The Next Mega-Caps: 7 Stocks Likely to Be Worth $100 Billion Soon

The 52-Week Low Club for Thursday

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

Eli Lilly : LLY

All Eli Lilly Articles

4 Merrill Lynch US 1 Portfolio Stocks With Big Total Return Potential

How Credit Suisse Views Major Pharma After ASCO

Merrill Lynch Picks ASCO Winners

Key Movers to Look for Ahead of ASCO

4 Dividend-Paying Stocks to Help Ride Out the Coming Volatile Summer

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

8 Stocks on the Move After ASCO Cancer Abstracts

3 Safe Blue Chip Stocks to Buy as Markets Could Be in Trouble

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

What to Expect When Eli Lilly Reports Earnings

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

5 Credit Suisse Focus List Stocks With the Most Upside

As Institutional Investors Continue to Sell, 4 Safe Dividend Stocks to Buy and Hold

The Next Mega-Caps: 7 Stocks Likely to Be Worth $100 Billion Soon

The 52-Week Low Club for Thursday

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account